Cited by

• Identification of Lynch syndrome among patients with colorectal cancer.

  Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A; EPICOLON Consortium. Moreira L, et al. JAMA. 2012 Oct 17;308(15):1555-65. doi: 10.1001/jama.2012.13088. JAMA. 2012. PMID: 23073952 Free PMC article.
• Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome.

  Steinke V, Engel C, Büttner R, Schackert HK, Schmiegel WH, Propping P. Steinke V, et al. Dtsch Arztebl Int. 2013 Jan;110(3):32-8. doi: 10.3238/arztebl.2013.0032. Epub 2013 Jan 18. Dtsch Arztebl Int. 2013. PMID: 23413378 Free PMC article. Review.
• A retrospective cohort study of genetic referral and diagnosis of Lynch syndrome in patients with cutaneous sebaceous lesions.

  Kattapuram M, Shabet C, Austin S, Jacobs MF, Koeppe E, Smith EH, Lowe L, Else T, Cha KB. Kattapuram M, et al. Fam Cancer. 2023 Jul;22(3):295-301. doi: 10.1007/s10689-022-00322-z. Epub 2022 Nov 28. Fam Cancer. 2023. PMID: 36437392
• Management of genetic syndromes predisposing to gynecologic cancers.

  Miesfeldt S, Lamb A, Duarte C. Miesfeldt S, et al. Curr Treat Options Oncol. 2013 Mar;14(1):34-50. doi: 10.1007/s11864-012-0215-3. Curr Treat Options Oncol. 2013. PMID: 23315239 Review.
• MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.

  Sheng WZ, Chen YS, Tu CT, He J, Zhang B, Gao WD. Sheng WZ, et al. World J Gastroenterol. 2016 Jun 28;22(24):5532-9. doi: 10.3748/wjg.v22.i24.5532. World J Gastroenterol. 2016. PMID: 27350731 Free PMC article.